Newsroom

Press / Medias

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

Apr 17, 2020

more +
News

LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...

Apr 15, 2020

more +
News

LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial

Mar 12, 2020

more +
Press / Medias

Georges Rawadi interviewed on Europe 1 radio – World Obesity Day

Mar 4, 2020

more +
News

LNC Therapeutics and the National Institute for Agricultural Research (INRA) sign research...

Dec 11, 2019

more +
Publications

Unlocking the Microbiome: Keys to Success, by Georges Rawadi

Dec 6, 2019

more +

YSOPIA Bioscience © 2023 - all rights reserved terms and conditions